辉瑞，拟100亿美元收购减肥药初创企业Metsera

Group 1 - Pfizer has agreed to acquire the weight loss startup Metsera for $10 billion [2] - The acquisition offer includes a purchase price of $86.25 per share, representing a 3.69% premium over Metsera's closing price of $83.18 last Friday [2] - The deal consists of an initial cash payment of $65.6 per share, with potential additional payments of up to $20.65 per share upon reaching specific milestones [2] Group 2 - Prior to this acquisition, Pfizer was in a bidding war with Novo Nordisk for Metsera [2]